Shinpoong Pharmaceutical Co.,Ltd Statistics

Total Valuation

Shinpoong Pharmaceutical Co.,Ltd has a market cap or net worth of KRW 529.50 billion. The enterprise value is 511.51 billion.

Market Cap	529.50B
Enterprise Value	511.51B

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Shinpoong Pharmaceutical Co.,Ltd has 51.26 million shares outstanding. The number of shares has increased by 0.14% in one year.

Current Share Class	n/a
Shares Outstanding	51.26M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.62%
Owned by Institutions (%)	5.03%
Float	34.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.40
PB Ratio	1.94
P/TBV Ratio	2.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-15.20
EV / Sales	2.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-29.51

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.16.

Current Ratio	2.92
Quick Ratio	2.05
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-2.47
Interest Coverage	-7.70

Financial Efficiency

Return on equity (ROE) is -12.48% and return on invested capital (ROIC) is -3.78%.

Return on Equity (ROE)	-12.48%
Return on Assets (ROA)	-3.49%
Return on Capital (ROIC)	-3.78%
Revenue Per Employee	264.34M
Profits Per Employee	-41.30M
Employee Count	815
Asset Turnover	0.60
Inventory Turnover	2.51

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.53% in the last 52 weeks. The beta is 0.81, so Shinpoong Pharmaceutical Co.,Ltd's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-22.53%
50-Day Moving Average	11,252.80
200-Day Moving Average	12,664.75
Relative Strength Index (RSI)	37.14
Average Volume (20 Days)	149,403

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shinpoong Pharmaceutical Co.,Ltd had revenue of KRW 215.44 billion and -33.66 billion in losses. Loss per share was -656.59.

Revenue	215.44B
Gross Profit	82.05B
Operating Income	-20.12B
Pretax Income	-28.41B
Net Income	-33.66B
EBITDA	-8.09B
EBIT	-20.12B
Loss Per Share	-656.59

Full Income Statement

Balance Sheet

The company has 62.05 billion in cash and 42.80 billion in debt, giving a net cash position of 19.26 billion or 375.64 per share.

Cash & Cash Equivalents	62.05B
Total Debt	42.80B
Net Cash	19.26B
Net Cash Per Share	375.64
Equity (Book Value)	268.17B
Book Value Per Share	5,206.58
Working Capital	127.35B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.28 billion and capital expenditures -5.06 billion, giving a free cash flow of -17.33 billion.

Operating Cash Flow	-12.28B
Capital Expenditures	-5.06B
Free Cash Flow	-17.33B
FCF Per Share	-338.12

Full Cash Flow Statement

Margins

Gross margin is 38.08%, with operating and profit margins of -9.34% and -16.71%.

Gross Margin	38.08%
Operating Margin	-9.34%
Pretax Margin	-13.19%
Profit Margin	-16.71%
EBITDA Margin	-3.75%
EBIT Margin	-9.34%
FCF Margin	n/a

Dividends & Yields

Shinpoong Pharmaceutical Co.,Ltd does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.14%
Shareholder Yield	-0.14%
Earnings Yield	-6.50%
FCF Yield	-3.35%

Dividend Details

Stock Splits

The last stock split was on December 29, 2014. It was a forward split with a ratio of 1.040008.

Last Split Date	Dec 29, 2014
Split Type	Forward
Split Ratio	1.040008

Scores

Shinpoong Pharmaceutical Co.,Ltd has an Altman Z-Score of 7.02.

Altman Z-Score	7.02
Piotroski F-Score	n/a